ARCHIVES

HPV DNA Testing Reduced Cervical Cancer Precursors

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

ACS Probably Will Accept Hammer’s Offer On Matching Funds For Survey

February 3, 1984

More Control Project Plans, Future RPs Listed

November 15, 1974

Clinical Trials Approved By NCI Last Month Are Listed

January 25, 2002

As von Eschenbach Prepares For New Assignment, NCI’s 2015 Goal Faces Uncertainty. New Strategic Plan Lists Steps to 2015. “The Vision Is Within Our Grasp,” von Eschenbach Says.

March 10, 2006

James Abbruzzese Moves to Duke Cancer Institute

September 27, 2013